Table 4 Baseline characteristic of patients with Diabetes Mellitus
| Â | Â | Unmatched | Propensity score matched | ||||
|---|---|---|---|---|---|---|---|
Characteristic | Diabetic Cohort (n = 413) | Inpatient Statin (n = 136) | Non Statin (n = 277) | p-value | Inpatient Statin (n = 129) | Non Statin (n = 129) | p-value |
Age, (years) n (%) | |||||||
 Median (IQR) | 66 (58–74) | 66 (59.25–75) | 66 (57–73) | 0.48 | 66 (59–75) | 68 (59.5–76) | 0.36 |
 18–30 | 3 (0.7) | 0 | 3 (1.1) | 0 | 1 (0.8) | ||
 31–45 | 27 (6.5) | 4 (2.9) | 23 (8.3) | 3 (2.3) | 11 (8.5) | ||
 46–64 | 144 (34.9) | 49 (36) | 95 (34.3) | 47 (36.4) | 36 (27.9) | ||
 ≥ 65 | 239 (57.9) | 83 (61) | 156 (56.3) | 79 (61.2) | 81 (62.8) | ||
Sex, n (%) | |||||||
 Male | 217 (52.5) | 68 (50) | 149 (53.8) | 0.47 | 64 (49.6) | 63 (48.8) | 0.9 |
 Female | 196 (47.5) | 68 (50) | 128 (46.2) | 65 (50.4) | 66 (51.2) | ||
Race, n (%) | |||||||
 Blacks | 314 (76) | 101 (74.3) | 213 (76.9) | 0.56 | 97 (75.2) | 97 (75.2) | 1 |
 Other races | 99 (24) | 35 (25.7) | 64 (23.1) | 32 (24.8) | 32 (24.8) | ||
BMI | |||||||
 Median (IQR) | 29.8 (25.7–36.15) | 29.95 (25.13–35.35) | 29.8 (26.05–36.55) | 0.65 | 30.3 (25.25–35.7) | 30 (26.15–35.75) | 0.79 |
 < 18.5 (underweight) | 8 (1.9) | 3 (2.2) | 5 (1.8) | 2 (1.6) | 3 (2.3) | ||
 18.5–24.9 (normal) | 82 (19.9) | 29 (21.3) | 53 (19.1) | 28 (21.7) | 20 (15.5) | ||
 25–29.9 (overweight) | 118 (28.6) | 36 (26.5) | 82 (29.6) | 33 (25.6) | 40 (31) | ||
 ≥ 30 (obese) | 205 (49.6) | 68 (50) | 137 (49.5) | 66 (51.2) | 66 (51.2) | ||
Comorbidities, n (%) | |||||||
 Preexisting lung diseases | 132 (32) | 46 (33.8) | 86 (31) | 0.57 | 45 (34.9) | 40 (31) | 0.51 |
 Coronary artery disease | 142 (34.4) | 60 (44.1) | 82 (29.6) | 0.004 | 58 (45) | 49 (38) | 0.26 |
 Hypertension | 378 (91.5) | 130 (95.6) | 248 (89.5) | 0.04 | 123 (95.3) | 117 (90.7) | 0.14 |
 Hyperlipidemia | 160 (38.7) | 71 (52.2) | 89 (32.1) |  < 0.001 | 65 (50.4) | 62 (48.1) | 0.71 |
 Congestive Heart Failure | 76 (18.4) | 31 (22.8) | 45 (16.2) | 0.11 | 29 (22.5) | 27 (20.9) | 0.76 |
 Stroke | 45 (10.9) | 20 (14.7) | 25 (9) | 0.08 | 18 (14) | 17 (13.2) | 0.86 |
 Cancer | 35 (8.5) | 11 (8.1) | 24 (8.7) | 0.84 | 11 (8.5) | 13 (10.1) | 0.67 |
 Chronic liver disease | 13 (3.1) | 0 | 13 (4.7) | 0.01 | 0 | 0 |  |
 Chronic kidney disease | 65 (15.7) | 24 (17.6) | 41 (14.8) | 0.46 | 24 (18.6) | 22 (17.1) | 0.75 |
 ESRD on dialysis | 53 (12.8) | 18 (13.2) | 35 (12.6) | 0.86 | 18 (14) | 14 (10.9) | 0.45 |
 Smoking | 176 (42.6) | 62 (45.6) | 114 (41.2) | 0.39 | 59 (45.7) | 61 (47.3) | 0.8 |
Insurance | |||||||
 Uninsured | 7 (1.7) | 3 (2.2) | 4 (1.4) | 0.5 | 3 (2.3) | 3 (2.3) | 0.77 |
 Medicaid | 87 (21.1) | 23 (16.9) | 64 (23.1) | 23 (17.8) | 27 (20.9) | ||
 Medicare | 296 (71.7) | 102 (75) | 194 (70) | 96 (74.4) | 95 (73.6) | ||
 Private | 23 (5.6) | 8 (5.9) | 15 (5.4) | 7 (5.4) | 4 (3.1) | ||
Days from symptom onset to hospital presentation | |||||||
 0–5 | 289 (70) | 95 (69.9) | 194 (70) | 0.26 | 92 (71.3) | 96 (74.4) | 0.36 |
 6–10 | 72 (17.4) | 28 (20.6) | 44 (15.9) | 28 (21.7) | 20 (15.5) | ||
 11–15 | 25 (6.1) | 5 93.7) | 20 (7.2) | 5 (3.9) | 10 (7.8) | ||
 16 +  | 8 (1.9) | 4 (2.9) | 4 (1.4) | 4 (3.1) | 3 (2.3) | ||
CURB-65 at presentation | |||||||
 0 | 77 (18.6) | 18 (13.2) | 59 (21.3) | 0.21 | 17 (13.2) | 18 (14) | 0.8 |
 1 | 123 (29.8) | 38 (27.9) | 85 (30.7) | 37 (28.7) | 38 (29.5) | ||
 2 | 145 (35.1) | 58 (42.6) | 87 (31.4) | 56 (43.4) | 48 (37.2) | ||
 3 | 53 (12.8) | 18 (13.2) | 35 (12.6) | 16 (12.4) | 21 (16.3) | ||
 4 | 8 (1.9) | 3 (2.2) | 5 (1.8) | 3 (2.3) | 3 (2.3) | ||
 5 | 5 (1.2) | 1 (0.7) | 4 (1.4) | 0 | 1 (0.8) | ||